LAVAL, Quebec, Dec. 21, 2012 (GLOBE NEWSWIRE) -- Neptune Technologies and Bioressources Inc. (Nasdaq:NEPT) (TSX:NTB), (" Neptune"), the pioneer in the krill oil industry, which holds a vast international patent estate covering krill oil compositions and methods of use, announces that it has filed for the revocation of all of Aker Biomarine ASA's Australian patents before the Federal Court.
More specifically, Neptune is seeking a declaration that all the claims in Aker's patents, namely the standard patent No. 2008231570 and the innovation patents Nos. 2012101332, 2012101333, 2012101334 and 2012101335 (the " Aker Patents") are, and at all materials times have been, invalid. The Aker Patents claim a krill oil composition and methods of extraction that lack novelty and are not patentable inventions. Neptune marketed its NKO ® krill oil product many years before Aker filed for these patents in Australia.
"The method and the compositions claimed in the Aker Patents are invalid and were obtained by false suggestion and misrepresentation, as stated in the documents filed by Neptune before the Federal Court of Australia," declared Neptune's Chief Global Strategy Officer, Dr. Tina Sampalis. "Neptune is the pioneer in the krill oil industry and, as such, we must protect our clients and our pharmaceutical subsidiaries, and ensure that invalid patents are not used to threaten Neptune's business partners. We are confident that the Federal Court of Australia will find that the Aker Patents are invalid."About Neptune Technologies & Bioressources Inc. Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids, or PUFAs. Neptune has a patented process of extracting oils from Antarctic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the U.S., European and Asian neutraceutical markets. Neptune's lead products, Neptune Krill Oil (NKO®) and ECOKRILL Oil (EKO™), generally come in capsule form and serve as a dietary supplement to consumers.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV